191 – 200 of 216
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Borgquist, Signe LU ; Jögi, Annika LU ; Ponten, Fredrik ; Rydén, Lisa LU
; Brennan, Donal J.
and Jirström, Karin
LU
(2008)
In Breast Cancer Research
10(5).
- Contribution to journal › Article
-
Mark
Different routine histopathology after frozen section of sentinel nodes in breast cancer
Grabau, Dorthe LU ; Rydén, Lisa LU
and Ingvar, Christian
LU
(2008)
6th Biennial International Sentinel Node Society Meeting
In Annals of Surgical Oncology
15(Suppl. 1).
p.37-38
- Contribution to journal › Published meeting abstract
-
Mark
Epidermal Growth Factor Receptor (EGFR) in primary breast cancer-protein expression, but not gene copy number, gives important prognostic information in tamoxifen treated patients
Rydén, Lisa LU
; Bendahl, Pär-Ola
LU
; Haglund, Mattias
; Grabau, Dorthe
LU
; Isola, Jorma
LU
and Fernö, Mårten
LU
(2008)
EBCC-6, European Breast Cancer Conference, 2008
In European Journal of Cancer Supplements
6(7).
p.187-187
- Contribution to journal › Published meeting abstract
-
Mark
Epidermal growth factor receptor (EGFR) and the estrogen receptor modulator amplified in breast cancer (AIB1) for predicting clinical outcome after adjuvant tamoxifen in breast cancer.
Dihge, Looket ; Bendahl, Pär-Ola LU ; Grabau, Dorthe LU ; Isola, Jorma ; Lövgren, Kristina LU ; Rydén, Lisa LU
and Fernö, Mårten
LU
(2008)
In Breast Cancer Research and Treatment
109(2).
p.255-262
- Contribution to journal › Article
-
Mark
HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
Rydén, Lisa LU
; Landberg, Göran
LU
; Stal, Olle
; Nordenskjold, Bo
; Fernö, Mårten
LU
and Bendahl, Pär-Ola
LU
(2008)
In Breast Cancer Research and Treatment
109(2).
p.351-357
- Contribution to journal › Article
-
Mark
High amplified in breast cancer 1 is a significant predictor of improved response to adjuvant tamoxifen in premenopausal women
Rundquist, Sara LU ; Bendahl, Pär-Ola LU ; Grabau, Dorthe LU ; Lövgren, Kristina LU ; Stål, O ; Ryden, Lisa LU
and Fernö, Mårten
LU
(2008)
31st Annual San Antonio Breast Cancer Symposium
- Contribution to conference › Abstract
-
Mark
Analys av HER2 i bröstcancer kvalitetssäkrad. Viktig behandlingsprediktiv och prognostisk faktor.
Fernö, Mårten LU ; Haglund, Monica ; Bendahl, Pär-Ola LU ; Olsson, Hans and Rydén, Lisa LU
(2008)
In Läkartidningen
105(32-33).
p.2181-2184
- Contribution to journal › Article
- 2007
-
Mark
Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: Analysis of 174 patients after SLN biopsy.
Rydén, Lisa LU
; Chebil, G
; Sjöström, L
; Pawlowski, R
and Jönsson, Per-Ebbe
LU
(2007)
In European Journal of Surgical Oncology
33(1).
p.33-38
- Contribution to journal › Article
-
Mark
Quantitative measurement of epidermal growth factor receptor is a negative predictive factor for tamoxifen response in hormone receptor - Positive premenopausal breast cancer
Giltnane, Jennifer M. ; Rydén, Lisa LU
; Cregger, Melissa
; Bendahl, Pär-Ola
LU
; Jirström, Karin
LU
and Rimm, David L.
(2007)
In Journal of Clinical Oncology
25(21).
p.3007-3014
- Contribution to journal › Article
- 2006
-
Mark
High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients.
Stendahl, Maria LU ; Rydén, Lisa LU
; Nordenskjöld, Bo
; Jönsson, Per Ebbe
; Landberg, Göran
LU
and Jirström, Karin
LU
(2006)
In Clinical Cancer Research
12(15).
p.4614-4618
- Contribution to journal › Article